This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raick, A. N. Search for Related Content PubMed PubMed Citation Articles by Raick, A. N.

Ultrastructural, Histological, and Biochemical Alterations Produced by 12-O-Tetradecanoyl-phorbol-13-acetate on Mouse Epidermis and Their Relevance to Skin Tumor Promotion¹

Department of Pathology, University of Toronto, 100 College Street, Toronto 2, Ontario, Canada

A single application of 12-O-tetradecanoyl-phorbol-13-acetate to mouse skin induces an ordered sequence of ultrastructural changes in the cells of all layers of the epidermis, which correlate well with the changes in the rate of precursor incorporation into protein, RNA, and DNA in the whole skin and also with changes in the thickness, number of nucleated cell layers, and mitotic index of the interfollicular epidermis.

The incorporation of orotic acid-5-³H into RNA is increased within 1 hr and reaches a peak by 3 hr. An increase in leucine-¹⁴C incorporation into protein is observed at 2 hr, but it is marked only after 6 to 7 hr and reaches a high plateau by 12 hr. The incorporation of thymidine-³H into DNA is markedly depressed for up to 9 hr and then sharply increases, to reach a first peak by 18 hr.

The mitotic index is depressed at 8 hr, reverting to control levels at 12 to 15 hr followed by an increase in mitotic activity, and reaching a peak by 24 hr. At 16 hr, there is a marked increase in the thickness of the interfollicular epidermis and in the number of its nucleated cell layers. At this time, the mitotic index and DNA synthesis are depressed or are at control level, indicating that the increase in nucleated cell layers is due to hypertrophy, not to proliferation.

Two hr after administration of the 12-O-tetradecanoyl-phorbol-13-acetate, the nucleoli of the basal cells are markedly enlarged, with an increase of the granular and fibrillar components. By 4 hr, the granular component is further increased, polysomes appear, and the intercellular spaces between basal cells are dilated. By 6 hr, the cytoplasm of the basal cells is enlarged and filled with polysomes. The mitochondria are enlarged and have more cristae and a less dense matrix. By 12 hr, the number of polysomes is further increased, and profiles of the granular reticulum and Golgi complexes are more numerous so that the stimulated basal cells resemble those of embryonic epidermis. By 24 hr, markedly hypertrophic cells and granular mitochondrial inclusions are frequently seen. By 48 hr, flattening, involution of the organelles, and accumulation of numerous keratohyalin granules occur in the cells of the upper layers.

Granular electron-dense material appears in the dilated intercellular spaces at 6 hr and increases until 36 hr, when it is also in the cisternae of the endoplasmic reticulum.

The superficial cells, normally flattened, are swollen by 2 hr, and they progressively regain their nuclear and cytoplasmic organization so that, by 12 hr, they resemble the stimulated basal cells.

Dark cells with ultrastructural features distinct from the other epidermal cells are observed after administration of 12-O-tetradecanoyl-phorbol-13-acetate, but are not found in normal or acetone-treated controls.

The relevance of the cellular events to tumor promotion is analyzed, and we propose that tumor promoters act by altering the normal differentiation pathway, thus enabling expression of the neoplastic phenotype.

¹ This work was supported by Grant-in-Aid 4201 from the National Cancer Institute of Canada and by Medical Research Council of Canada Grant MA-4340.

Received 6/27/72. Accepted 10/20/72.

This article has been cited by other articles:

				B Risek, A Pozzi, and N. Gilula Modulation of gap junction expression during transient hyperplasia of rat epidermis J. Cell Sci., January 5, 1998; 111(10): 1395 - 1404. [Abstract] [PDF]

				R.S. Dewdney, C.J. Soper, and D. Anderson Characterization of Lymphocyte Stimulation by Phorbol Related Compounds Human and Experimental Toxicology, March 1, 1988; 7(2): 153 - 159. [Abstract] [PDF]

				P. D. Fries, D. S. Fohrman, and D. H. Char Phorbol Ester-Induced Orbital Myositis Arch Ophthalmol, September 1, 1987; 105(9): 1273 - 1276. [Abstract] [PDF]

				G.R.N. Jones Skin Cancer: Risk to Individuals Using the Tumour Promoter Benzoyl Peroxide for Acne Treatment Human and Experimental Toxicology, January 1, 1985; 4(1): 75 - 78. [PDF]

				R. Lavker and T. Sun Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations Science, March 5, 1982; 215(4537): 1239 - 1241. [Abstract] [PDF]

				T.J. Slaga, S.M. Fischer, L.L. Triplett, and S. Nesnow Comparison of Complete Carcinogenesis and Tumor Initiation and Promotion in Mouse Skin: The Induction of Papillomas by Tumor Initiation-Promotion a Reliable Short Term Assay International Journal of Toxicology, January 1, 1982; 1(1): 83 - 99. [Abstract] [PDF]

				L. Lee and I. Weinstein Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors Science, October 20, 1978; 202(4365): 313 - 315. [Abstract] [PDF]

				D. Ishii, E Fibach, H Yamasaki, and I. Weinstein Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells Science, May 5, 1978; 200(4341): 556 - 559. [Abstract] [PDF]